{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:56:49Z","timestamp":1781027809502,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T00:00:00Z","timestamp":1275609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00417-010-1406-x","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T10:41:03Z","timestamp":1275561663000},"page":"1601-1609","source":"Crossref","is-referenced-by-count":28,"title":["Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients"],"prefix":"10.1007","volume":"248","author":[{"given":"Yosuke","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Okumichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Takumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiya","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,4]]},"reference":[{"key":"1406_CR1","first-page":"1649","volume":"41","author":"S Ishida","year":"2000","unstructured":"Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, Ikeda E (2000) Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1649\u20131656","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1406_CR2","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/1078-0432.CCR-03-0605","volume":"10","author":"BI Rini","year":"2004","unstructured":"Rini BI, Halabi S, Taylor J, Small EJ, Schilsky RL; Cancer and Leukemia Group B (2004) Cancer and Leukemia Group B 90206: a randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma. Clin Cancer Res 10:2584\u20132586","journal-title":"Clin Cancer Res"},{"key":"1406_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","volume":"26","author":"RF Spaide","year":"2006","unstructured":"Spaide RF, Fisher YL (2006) Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26:275\u2013278","journal-title":"Retina"},{"issue":"1","key":"1406_CR4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00417-006-0466-4","volume":"245","author":"R Lazic","year":"2007","unstructured":"Lazic R, Gabric N (2007) Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245(1):68\u201373","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1406_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/112067210701700220","volume":"17","author":"Z Vatavuk","year":"2007","unstructured":"Vatavuk Z, Bencic G, Mandic Z (2007) Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 17:269\u2013271","journal-title":"Eur J Ophthalmol"},{"key":"1406_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","volume":"38","author":"A Travassos","year":"2007","unstructured":"Travassos A, Teixeira S, Ferreira P, Regadas I, Travassos AS, Esperancinha FE et al (2007) Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 38:233\u2013237","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1406_CR7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006982-200603000-00018","volume":"26","author":"JO Mason 3rd","year":"2006","unstructured":"Mason JO 3rd, Albert MA Jr, Vail R (2006) Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 26:356\u2013357","journal-title":"Retina"},{"key":"1406_CR8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","volume":"26","author":"RL Avery","year":"2006","unstructured":"Avery RL (2006) Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 26:352\u2013354","journal-title":"Retina"},{"key":"1406_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00006982-200603000-00017","volume":"26","author":"FH Davidorf","year":"2006","unstructured":"Davidorf FH, Mouser JG, Derick RJ (2006) Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 26:354\u2013356","journal-title":"Retina"},{"key":"1406_CR10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","volume":"142","author":"S Grisanti","year":"2006","unstructured":"Grisanti S, Bieste S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU (2006) Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol 142:158\u2013160","journal-title":"Am J Ophthalmol"},{"key":"1406_CR11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","volume":"142","author":"ME Iliev","year":"2006","unstructured":"Iliev ME, Domingo D, Wolf-Schnurrbursch U, Wolf S, Sarra G (2006) Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 142:1054\u20131056","journal-title":"Am J Ophthalmol"},{"key":"1406_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000099248","volume":"39","author":"JB Jonas","year":"2007","unstructured":"Jonas JB, Spandau UH, Schlichtenbrede F (2007) Intravitreal bevacizumab for filtering surgery. Opthalmic Res 39:121\u2013122","journal-title":"Opthalmic Res"},{"key":"1406_CR13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3928\/1542-8877-20060301-11","volume":"37","author":"MY Kahook","year":"2006","unstructured":"Kahook MY, Schuman JS, Noecker RJ (2006) Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging 37:144\u2013146","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1406_CR14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.iae.0000230425.31296.3b","volume":"26","author":"JO Mason 3rd","year":"2006","unstructured":"Mason JO 3rd, Albert MA Jr, Mays A, Vail R (2006) Regression of neovascular iris vessels by intravitreal injection of bevacizumab. Retina 26:839\u2013841","journal-title":"Retina"},{"key":"1406_CR15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1600-0420.2006.00731.x","volume":"84","author":"PJ Silva","year":"2006","unstructured":"Silva PJ, Jorge R, Alves CR, Rodrigues ML, Scott IU (2006) Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand 84:556\u2013557","journal-title":"Acta Ophthalmol Scand"},{"key":"1406_CR16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3180457c47","volume":"16","author":"S Yazdani","year":"2007","unstructured":"Yazdani S, Hendi K, Pakravan M (2007) Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma 16:437\u2013439","journal-title":"J Glaucoma"},{"key":"1406_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/002215540405200105","volume":"52","author":"AN Witmer","year":"2004","unstructured":"Witmer AN, van Blijswijk BC, van Noorden CJ, Vrensen GF, Schlingemann RO (2004) In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A. J Histochem Cytochem 52:39\u201352","journal-title":"J Histochem Cytochem"},{"key":"1406_CR18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/bjo.2007.117309","volume":"91","author":"A Iriyama","year":"2007","unstructured":"Iriyama A, Chen YN, Tamaki Y, Yanagi Y (2007) Effect of anti VEGF-antibody on retinal ganglion cells in rats. Br J Opthalmol 91:1230\u20131233","journal-title":"Br J Opthalmol"},{"key":"1406_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2006.03.058","volume":"142","author":"SJ Bakri","year":"2006","unstructured":"Bakri SJ, Cameron D, McCannel CA, Pulido JS, Marler RJ (2006) Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol 142:162\u2013164","journal-title":"Am J Ophthalmol"},{"key":"1406_CR20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajo.2007.03.007","volume":"143","author":"S Peters","year":"2007","unstructured":"Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Opthalmol 143:995\u20131002","journal-title":"Am J Opthalmol"},{"key":"1406_CR21","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0161-6420(01)00775-8","volume":"108","author":"JA Sivak-Callcott","year":"2001","unstructured":"Sivak-Callcott JA, O\u2019Day DM, Gass JD, Tsai JC (2001) Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 108:1767\u20131778","journal-title":"Ophthalmology"},{"key":"1406_CR22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/bjo.2007.129833","volume":"92","author":"A Miki","year":"2008","unstructured":"Miki A, Oshima Y, Otori Y, Kamei M, Tano Y (2008) Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Opthalmol 92:1431\u20131433","journal-title":"Br J Opthalmol"},{"issue":"6","key":"1406_CR23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000095865","volume":"220","author":"Y Kiuchi","year":"2006","unstructured":"Kiuchi Y, Sugimoto R, Nakae K, Saito Y, Ito S (2006) Trabeculectomy with itomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica 220(6):383\u2013388","journal-title":"Ophthalmologica"},{"issue":"5","key":"1406_CR24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.ijg.0000212270.27359.64","volume":"15","author":"U Elgin","year":"2006","unstructured":"Elgin U, Berker N, Batman A, Simsek T, Cankaya B (2006) Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma. J Glaucoma 15(5):466\u2013470","journal-title":"J Glaucoma"},{"issue":"12","key":"1406_CR25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00417-006-0321-7","volume":"244","author":"Y Kiuchi","year":"2006","unstructured":"Kiuchi Y, Nakae K, Saito Y, Ito S, Ito N (2006) Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 244(12):1627\u20131632","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1406_CR26","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2008.02.026","volume":"115","author":"T Wakabayashi","year":"2008","unstructured":"Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F et al (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571\u20131580","journal-title":"Ophthalmology"},{"issue":"7","key":"1406_CR27","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1167\/iovs.07-1265","volume":"49","author":"S Kaempf","year":"2008","unstructured":"Kaempf S, Johnen S, Salz AK, Weinberger A, Walter P, Thumann G (2008) Effects of bevacizumab (Avastin) on retinal cells in organotypic culture. Invest Ophthalmol Vis Sci 49(7):3164\u20133171","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1406_CR28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1755-3768.2009.01648.x","volume":"88","author":"Y Saito","year":"2010","unstructured":"Saito Y, Higashide T, Takeda H, Ohkubo S, Sugiyama K (2010) Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmologica 88(1):96\u2013102","journal-title":"Acta Ophthalmologica"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1406-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1406-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1406-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T10:14:32Z","timestamp":1591352072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1406-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,4]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1406-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,4]]}}}